Legal & General Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-4,179,950
Closed -$415M 3422
2019
Q3
$415M Sell
4,179,950
-8,115
-0.2% -$771K 0.22% 98
2019
Q2
$387M Sell
4,188,065
-119,362
-3% -$11.3M 0.21% 104
2019
Q1
$406M Buy
4,307,427
+790,907
+22% +$69.2M 0.23% 95
2018
Q4
$225M Buy
3,516,520
+209,564
+6% +$15.5M 0.17% 131
2018
Q3
$296M Buy
3,306,956
+3,858
+0.1% +$341K 0.21% 106
2018
Q2
$262M Sell
3,303,098
-249,341
-7% -$20.7M 0.2% 115
2018
Q1
$317M Sell
3,552,439
-191,813
-5% -$18.4M 0.24% 87
2017
Q4
$391M Sell
3,744,252
-84,127
-2% -$9.49M 0.28% 76
2017
Q3
$558M Buy
3,828,379
+76,872
+2% +$10.5M 0.42% 44
2017
Q2
$487M Buy
3,751,507
+163,884
+5% +$20.1M 0.39% 45
2017
Q1
$446M Buy
3,587,623
+147,263
+4% +$17.6M 0.38% 46
2016
Q4
$398M Buy
3,440,360
+89,230
+3% +$9.94M 0.37% 51
2016
Q3
$350M Buy
3,351,130
+32,068
+1% +$3.47M 0.35% 55
2016
Q2
$327M Sell
3,319,062
-6,098
-0.2% -$631K 0.34% 59
2016
Q1
$333M Buy
3,325,160
+46,095
+1% +$4.75M 0.37% 55
2015
Q4
$393M Buy
3,279,065
+63,373
+2% +$7.33M 0.44% 45
2015
Q3
$348M Buy
3,215,692
+88,835
+3% +$11M 0.42% 47
2015
Q2
$362M Buy
3,126,857
+28,636
+0.9% +$3.27M 0.43% 50
2015
Q1
$357M Sell
3,098,221
-55,549
-2% -$6.64M 0.43% 48
2014
Q4
$353M Sell
3,153,770
-95,750
-3% -$10.1M 0.42% 48
2014
Q3
$308M Sell
3,249,520
-128,665
-4% -$11.6M 0.37% 57
2014
Q2
$290M Sell
3,378,185
-32,661
-1% -$2.48M 0.34% 66
2014
Q1
$238M Sell
3,410,846
-108,274
-3% -$8.57M 0.29% 80
2013
Q4
$297M Sell
3,519,120
-27,032
-0.8% -$2.14M 0.36% 59
2013
Q3
$273M Sell
3,546,152
-93,840
-3% -$6.58M 0.36% 62
2013
Q2
$213M Buy
+3,639,992
New +$219M 0.29% 78

Other funds holding CELG

Legal & General Group's CELG Position: Q4 2019 in Review

Legal & General Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,179,950 shares — an estimated $415M sold.

Legal & General Group first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $558M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Legal & General Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Legal & General Group sold 4,179,950 Celgene Corp shares in Q4 2019, an estimated $415M.
  • Legal & General Group first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Legal & General Group's Celgene Corp position peaked at $558M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Legal & General Group's 13F filing for Q4 2019, filed 13 Feb 2020.